User profiles for Ugo Ramenghi

ugo ramenghi

Università di Torino
Verified email at unito.it
Cited by 10301

[HTML][HTML] Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

…, D Montagna, GL Marseglia, F Licciardi, U Ramenghi… - Nature medicine, 2022 - nature.com
Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of
children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might …

Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference

…, N Dahl, BP Alter, S Sheth, U Ramenghi… - British journal of …, 2008 - Wiley Online Library
Diamond Blackfan anaemia (DBA) is a rare, genetically and clinically heterogeneous, inherited
red cell aplasia. Classical DBA affects about seven per million live births and presents …

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

…, E Neufeld, T Taube, U Ramenghi… - Blood, The Journal …, 2012 - ashpublications.org
Treatments for immune thrombocytopenic purpura (ITP) providing durable platelet
responses without continued dosing are limited. Whereas complete responses (CRs) to B-cell …

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

M Zecca, B Nobili, U Ramenghi… - Blood, The Journal …, 2003 - ashpublications.org
Autoimmune hemolytic anemia (AIHA) in children is sometimes characterized by a severe
course, requiring prolonged administration of immunosuppressive therapy. Rituximab is able …

X–linked thrombocytopenia and Wiskott–Aldrich syndrome are allelic diseases with mutations in the WASP gene

…, D Brugnoni, D Strina, MC Patrosso, U Ramenghi… - Nature …, 1995 - nature.com
X–linked thrombocytopenia (XLT) is a rare recessive hereditary disorder characterized by
isolated thrombocytopenia with small–sized platelets. The XLT locus has been located to …

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

…, V Lebedev, R Lemons, D Pospisilova, U Ramenghi… - The Lancet, 2015 - thelancet.com
Background The thrombopoietin receptor agonist eltrombopag has been shown to be safe,
tolerable, and effective for adults with chronic immune thrombocytopenia. We aimed to …

Chloride Channel ClCN7 Mutations Are Responsible for Severe Recessive, Dominant, and Intermediate Osteopetrosis

…, E Mihci, LD Notarangelo, U Ramenghi… - Journal of bone and …, 2003 - academic.oup.com
Among 94 osteopetrotic patients presenting with a severe clinical picture and diagnosed
early in life, 12 bore mutations in the ClCN7 gene, but only 7 of them had the expected two …

The ribosomal basis of Diamond‐Blackfan Anemia: mutation and database update

…, E Atsidaftos, JM Lipton, SR Ellis, U Ramenghi… - Human …, 2010 - Wiley Online Library
Diamond‐Blackfan Anemia (DBA) is characterized by a defect of erythroid progenitors and,
clinically, by anemia and malformations. DBA exhibits an autosomal dominant pattern of …

Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression

…, S Ball, C Niemeyer, U Ramenghi… - Blood, The Journal …, 1999 - ashpublications.org
Mutations of the ribosomal protein S19 (RPS19) gene were recently identified in 10 patients
with Diamond Blackfan anemia (DBA). To determine the prevalence of mutations in this …

Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease

…, B Rocca, U Russo, U Ramenghi… - Human …, 2008 - Wiley Online Library
MYH9‐related disease (MYH9‐RD) is a rare autosomal‐dominant disorder caused by
mutations in MYH9, the gene for the heavy chain of nonmuscle myosin IIA (NMMHC‐IIA). All …